Accrued Expenses and Other Current Liabilities

9 Months Ended

Sep. 30, 2025

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

(in thousands)	September 30, 2025	December 31, 2024
Accrued bonus and other payroll related	$28,116	$28,260
Accrued legal settlement	30,898	25,000
Accrued marketing	11,582	14,311
Income taxes payable	7,677	1,457
Reimbursable liabilities (1)	42,305	15,798
Deferred revenue	6,282	6,036
Other accrued expenses	16,512	8,268
Total accrued expenses and other current liabilities	$143,372	$99,130

_____________________________________________________

(1)Represents amounts owed to third parties on behalf of and, as applicable, reimbursable from, pharma

manufacturers in connection with our consumer affordability solutions, including consumer direct pricing.

Deferred revenue represents payments received in advance of providing services for certain advertising contracts with

customers and subscriptions. We expect substantially all of the deferred revenue at September 30, 2025 will be recognized

as revenue within the subsequent twelve months. Of the $6.0 million of deferred revenue at December 31, 2024, $0.5 million

and $5.7 million was recognized as revenue during the three and nine months ended September 30, 2025, respectively.

Revenue recognized during the three and nine months ended September 30, 2024 of $0.5 million and $6.9 million,

respectively, was included as deferred revenue at December 31, 2023.